UBS Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-91,084
| Closed | -$78K | – | 7654 |
|
|
2019
Q4 | $78K | Buy |
91,084
+39,500
| +77% | +$33.8K | ﹤0.01% | 5081 |
|
|
2019
Q3 | $29K | Sell |
51,584
-26,013
| -34% | -$14.6K | ﹤0.01% | 5563 |
|
|
2019
Q2 | $40K | Buy |
77,597
+9,272
| +14% | +$4.78K | ﹤0.01% | 5247 |
|
|
2019
Q1 | $31K | Sell |
68,325
-4,706
| -6% | -$2.14K | ﹤0.01% | 5110 |
|
|
2018
Q4 | $35K | Buy |
73,031
+4,659
| +7% | +$2.23K | ﹤0.01% | 5471 |
|
|
2018
Q3 | $36K | Buy |
68,372
+5,776
| +9% | +$3.04K | ﹤0.01% | 5521 |
|
|
2018
Q2 | $31K | Sell |
62,596
-16,082
| -20% | -$7.96K | ﹤0.01% | 5458 |
|
|
2018
Q1 | $33K | Sell |
78,678
-13,619
| -15% | -$5.71K | ﹤0.01% | 5176 |
|
|
2017
Q4 | $35K | Buy |
92,297
+6,665
| +8% | +$2.53K | ﹤0.01% | 5176 |
|
|
2017
Q3 | $31K | Sell |
85,632
-21,732
| -20% | -$7.87K | ﹤0.01% | 5256 |
|
|
2017
Q2 | $41K | Sell |
107,364
-2,468
| -2% | -$942 | ﹤0.01% | 4893 |
|
|
2017
Q1 | $49K | Buy |
109,832
+961
| +0.9% | +$429 | ﹤0.01% | 4651 |
|
|
2016
Q4 | $41K | Sell |
108,871
-20,577
| -16% | -$7.75K | ﹤0.01% | 5072 |
|
|
2016
Q3 | $35K | Buy |
129,448
+8,300
| +7% | +$2.24K | ﹤0.01% | 4941 |
|
|
2016
Q2 | $29K | Sell |
121,148
-28,022
| -19% | -$6.71K | ﹤0.01% | 5122 |
|
|
2016
Q1 | $17K | Sell |
149,170
-23,158
| -13% | -$2.64K | ﹤0.01% | 5506 |
|
|
2015
Q4 | $19K | Buy |
172,328
+37,965
| +28% | +$4.19K | ﹤0.01% | 5637 |
|
|
2015
Q3 | $25K | Buy |
134,363
+7,518
| +6% | +$1.4K | ﹤0.01% | 5284 |
|
|
2015
Q2 | $89K | Buy |
126,845
+33,044
| +35% | +$23.2K | ﹤0.01% | 4377 |
|
|
2015
Q1 | $64K | Buy |
93,801
+8,613
| +10% | +$5.88K | ﹤0.01% | 4495 |
|
|
2014
Q4 | $67K | Buy |
+85,188
| New | +$67K | ﹤0.01% | 4499 |
|